Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety HuidaGene, under loosened oversight, was testing CRISPR therapy in boy with muscular dystrophy

https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/ By Jason Mast and Brian YangAug. 5, 2026